Government Identifies Neurodegenerative Disorder Treatment as Key Investment Initiative

Published: 2005-02-01 07:00:00

Updated: 2005-02-01 07:00:00

Among the list of ten strategic investment initiatives identified by the government, based on their potential market commercialization and profitability assessments, the development of novel treatments for degenerative brain disorders has been selected under a full-pledged support by the Ministry...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK